Drug Discovery Chemistry & External R&D SupportVienna, Austria · International
Forster Discovery
forstering better molecules
Computational drug discovery

Computational support for better compound decisions.

Structure- and physics-based molecular modeling, docking and cheminformatics are used where appropriate to help prioritize compounds, test hypotheses and focus experimental work where it matters most.

Better prioritization. Fewer low-value compounds. Clearer experimental hypotheses.

What it helps with

Start with the program question, not the software.

The toolbox is used when a chemistry or structural decision would benefit from systematic computational analysis before more compounds are made or more experiments are commissioned.

What should we make next?

Prioritize plausible designs when synthesis capacity or assay bandwidth is limited.

Does this design make structural sense?

Compare proposed binding modes, interactions and alternative structural interpretations.

Why is the SAR behaving this way?

Use structural and series-level analysis to generate testable explanations for unexpected activity patterns.

Could stereochemistry, conformation or protonation change the answer?

Compare relevant molecular states and alternative poses when they could materially affect the design decision.

Which virtual ideas are worth synthesis?

Reduce larger enumerated sets to a chemically and experimentally practical shortlist.

Are we missing a better hypothesis?

Stress-test the current design rationale against alternative poses, analogues and structural comparisons.

Toolbox capabilities

Structure-based and cheminformatics workflows that support compound decisions.

01

Structure preparation & pocket analysis

Protein-structure selection, preparation, alignment, binding-site comparison and interaction analysis to establish a useful structural basis for the question.

02

Docking & pose assessment

Pose generation, scoring, comparison and interaction-based review, with emphasis on comparative interpretation rather than a single docking score.

03

Compound prioritization & ranking

Integrating structural compatibility, medicinal-chemistry context, molecular properties and project-specific criteria to rank ideas for follow-up.

04

Cheminformatics & series analysis

Similarity, substructure, matched-pair, scaffold and analogue analysis using reproducible RDKit / Python workflows.

05

Virtual library triage & design support

Filtering and prioritization of virtual or enumerated compound sets, including pharmacophore and structure-guided design support where appropriate.

06

Custom project workflows

Purpose-built analyses for a defined program question, rather than forcing every project through the same fixed software pipeline.

How it fits into a project

From scientific question to an experimental recommendation.

01
QuestionDefine the decision that actually matters for the program.
02
Data & structure reviewAssess structures, assay data, series context and known limitations.
03
Computational analysisRun the structure-based or cheminformatics workflow appropriate to the question.
04
Ranked hypothesesCompare plausible explanations or compounds instead of relying on one number.
05
RecommendationTranslate the analysis into specific compounds, experiments or next decisions.
The output is a recommendation, not a docking score. Computational evidence is interpreted together with medicinal chemistry, SAR, synthetic feasibility, DMPK and the practical constraints of the program.
Where it can add value

Most useful when plausible ideas outnumber experimental bandwidth.

Hit and lead series

Focus the next design cycle when many analogues are plausible but synthesis or assay capacity is limited.

Ambiguous or unexpected SAR

Compare structural explanations and generate testable hypotheses when activity changes are clear but the reason is not.

TPD / molecular glues

Assess programs where binary binding, ternary-complex geometry and interface effects may all influence compound behavior.

Outsourced or virtual programs

Review CRO proposals, design logic and larger virtual libraries before synthesis, procurement or other resources are committed.

What the customer receives

Outputs designed to support action, not just analysis.

✓
Prioritized compound shortlist with scientific rationale
✓
Annotated poses or structural comparisons where relevant
✓
Comparison of competing structural or SAR hypotheses
✓
Property, similarity or series-level analysis
✓
Explicit uncertainties, assumptions and model limitations
✓
Recommended next compounds, experiments or design questions
✓
Concise decision memo and supporting technical material
✓
Reusable analysis outputs for internal or CRO discussion
Scientific positioning

Decision support, not black-box prediction.

Docking scores, structural models and computational rankings are treated as comparative evidence rather than direct predictions of potency, degradation or clinical performance. Conclusions are reported with uncertainty and interpreted alongside experimental data, medicinal chemistry and synthetic feasibility.

Have a compound series or structural question?

Start with the decision you need to make.

Share the question and whatever data or structures you already have. I can then define whether computational analysis is likely to change the decision and what a useful, bounded piece of work would look like.

Dr. Francis ForsterForster DiscoveryVienna, Austria · working internationally[email protected]LinkedIn